Abiopharma

🔍 Corre Partners Management, LLC (Executive)

Company: NN INC (NNBR)

Report Date: 2026-04-23

Detailed Transactions and Holdings:

• Sold 406,779 shares of Common Stock, par value $0.01 per share at $2.6904 per share (Direct)
  Date: 2026-04-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,304,652.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 148,526 shares of Common Stock, par value $0.01 per share at $2.6904 per share (Direct)
  Date: 2026-04-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 412,427.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 8,936 shares of Common Stock, par value $0.01 per share at $2.5138 per share (Direct)
  Date: 2026-04-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,295,716.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 3,263 shares of Common Stock, par value $0.01 per share at $2.5138 per share (Direct)
  Date: 2026-04-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 409,164.00 | transaction_form_type: 4 | Footnotes: F2, F5
• Sold 99,745 shares of Common Stock, par value $0.01 per share at $2.6295 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,195,971.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Sold 36,420 shares of Common Stock, par value $0.01 per share at $2.6295 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 372,744.00 | transaction_form_type: 4 | Footnotes: F3, F5

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.49 to $2.88. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.50 to $2.54. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.52 to $2.7099. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F4: The reported securities are directly owned by Corre Opportunities Qualified Master Fund, LP (the "Qualified Master Fund"). The reported securities may be deemed beneficially owned by Corre Partners Management, LLC ("Corre"), the investment manager of the Qualified Master Fund, Corre Partners Advisors, LLC ("Corre GP"), the general partner of the Qualified Master Fund, and John Barrett, the managing member of Corre and Corre GP, each a Reporting Person. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• F5: The reported securities are directly owned by Corre Horizon Fund, LP (the "Partnership"). The reported securities may be deemed beneficially owned by Corre, the investment manager of the Partnership, Corre GP, the general partner of the Partnership, and John Barrett, the managing member of Corre and Corre GP, each a Reporting Person. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• REMARKS: John Barrett will be reported as a Reporting Person on a subsequent Form 4 made by Corre once CIK codes for John Barrett are received.